Schieber Andrew T

Yuan Fan, Schieber Andrew T, Camras Lucinda J, Harasymowycz Paul J, Herndon Leon W, Allingham R Rand

Mathematical modeling showed glaucoma devices bypassing the trabecular meshwork and dilating Schlemm's canal significantly increase outflow facility, with longer dilation leading to greater improvement, impacting clinical efficacy.

Grierson Ian, Saheb Hady, Kahook Malik Y, Johnstone Murray A, Ahmed Iqbal I K, Schieber Andrew T et al.

This study found a novel Nitinol implant (Hydrus Microstent) for glaucoma showed excellent biocompatibility with minimal inflammation in animal models, suggesting safe long-term use for improving aqueous humor outflow.

Camras Lucinda J, Yuan Fan, Fan Shan, Samuelson Thomas W, Ahmed Ike K, Schieber Andrew T et al.

This study found the Hydrus microstent significantly increased outflow facility in human eyes ex vivo, suggesting it's an effective glaucoma treatment by improving fluid drainage.